SEBIO 2018 Board of Directors

Officers:
Chair: Todd Sherer, PhD, Emory University, Office of Technology Transfer
Vice-Chair and Secretary: Tina McKeon, Kilpatrick Townsend & Stockton, LLP
Secretary:  Tom Callaway, MD, Life Science Partners
Treasurer: Mark Baxter, Ernst & Young
Ex Officio: Sue Washer, AGTC

Executive Committee:
Brian Adams, PhD, Arbor Pharmaceuticals, Inc.
Mark Baxter, Ernst & Young
Tom Callaway, MD, Life Science Partners
Becky Kaufman, King & Spalding LLP
Tina McKeon, Kilpatrick Townsend & Stockton, LLP
Jennifer Sherer, MAC
Todd Sherer, PhD, Emory University, Office of Technology Transfer
Sue Washer, AGTC

Directors:
Russell Allen, Georgia Bio
William Brooke, Harbert Ventures Partners
Gerry Brunk, Lumira Ventures
Nancy Bryan, BioFlorida
Joe Cook, III, Mountain Group Partners
Todd Creech, HealthQuest Capital
David Day, Southeast BIO
Machelle Dunavan-Shields, Butler Snow
Greg Duncan, Celtaxsys, Inc.
Ken Eheman, Wyrick Robbins
Tom Fagley, Hughes Pittman & Gupton, LLP
Jeff Gallagher, Virginia Biotechnology Association
H. Lee Herron, DVM, Georgia Research Alliance
Frank Hunt, PNP Therapeutics, Inc.
Sam Konduros, SC BIO
Andrew Krouse, Cavion, LLC
Sharon Krueger, University of Virginia, Office of the VP for Research
Scott McCarty, Silicon Valley Bank
Bibhash Mukhopadhyay, PhD, New Enterprise Associates
Kathy Nugent, PhD, UAB Institute for Innovation and Entrepreneurship
Jim O’Connell, University of Florida, Office of Technology Licensing
Dan O’Korn, Hutchison Law Group, PLLC
David Pierson, Syngenta Crop Protection
Robin Rasor, Duke University, Office of Technology Transfer
James Rosen, Artizan Biosciences
David Stern, Contego Medical
Ken Tindall, PhD, North Carolina Biotechnology Center
Evan Travis, Square 1 Bank
Abby Trotter, Life Science Tennessee
Miriam Wilson, Council for Entrepreneurial Development (CED)
Ford Worthy, Pappas Ventures
Karen Zederej, AxoGen, Inc.